Shopping Cart 0
Cart Subtotal
USD 0

Renata Ltd (RENATA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Renata Ltd (Renata), formerly Pfizer Limited, is a healthcare solution provider that develops and commercializes pharmaceutical and nutritional products for both human and animal use. The company manufactures generic pharmaceutical products including hormones, contraceptives, anti cancer drugs, oral preparations, and other drugs. Its pharmaceutical product portfolio comprises amino acid supplement, anti viral preparation, anti allergic preparations, anti asthmatic preparation, anti bacterial preparations, among others. The company's animal health and nutrition products include ruminotorics, acidifier, multivitamin and others. Renata has its facilities in Mirpur, Rajendrapur and Bhaluka. The company exports its products to various countries including Afghanistan, Belize, Cambodia, Hong Kong, Kenya, the UK, and others. Renata is headquartered in Dhaka, Bangladesh.

Renata Ltd (RENATA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Renata Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Renata Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Renata Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Renata Enters Into Agreement With Population Services Lanka For Distributing Emcon 10

Renata Enters Into Joint Venture With Natco Pharma To Form Renata Oncology 10

Debt Offering 11

Renata Completes Private Placement Of Bonds Due 2014 For US$12 Million 11

Renata Ltd-Key Competitors 12

Key Employees 13

Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Appendix 15

Methodology 15

About GlobalData 15

Contact Us 15

Disclaimer 15


List Of Figure

List of Figures

Renata Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Renata Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Renata Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Renata Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Renata Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

Renata Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Renata Enters Into Agreement With Population Services Lanka For Distributing Emcon 10

Renata Enters Into Joint Venture With Natco Pharma To Form Renata Oncology 10

Renata Completes Private Placement Of Bonds Due 2014 For US$12 Million 11

Renata Ltd, Key Competitors 12

Renata Ltd, Key Employees 13

Renata Ltd, Other Locations 14

Renata Ltd, Subsidiaries 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Renata Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Renata Ltd (Renata), formerly Pfizer Limited, is a healthcare solution provider that develops and commercializes pharmaceutical and nutritional products for both human and animal use. The company manufactures generic pharmaceutical products including hormones, contraceptives, anti cancer drugs, oral preparations, and other drugs. Its pharmaceutical product portfolio comprises amino acid supplement, anti viral preparation, anti allergic preparations, anti asthmatic preparation, anti bacterial preparations, among others. The company's animal health and nutrition products include ruminotorics, acidifier, multivitamin and others. Renata has its facilities in Mirpur, Rajendrapur and Bhaluka. The company exports its products to various countries including Afghanistan, Belize, Cambodia, Hong Kong, Kenya, the UK, and others. Renata is headquartered in Dhaka, Bangladesh.

Renata Ltd (RENATA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Renata Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Renata Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Renata Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Renata Enters Into Agreement With Population Services Lanka For Distributing Emcon 10

Renata Enters Into Joint Venture With Natco Pharma To Form Renata Oncology 10

Debt Offering 11

Renata Completes Private Placement Of Bonds Due 2014 For US$12 Million 11

Renata Ltd-Key Competitors 12

Key Employees 13

Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Appendix 15

Methodology 15

About GlobalData 15

Contact Us 15

Disclaimer 15


List Of Figure

List of Figures

Renata Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Renata Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Renata Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Renata Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Renata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Renata Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

Renata Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Renata Enters Into Agreement With Population Services Lanka For Distributing Emcon 10

Renata Enters Into Joint Venture With Natco Pharma To Form Renata Oncology 10

Renata Completes Private Placement Of Bonds Due 2014 For US$12 Million 11

Renata Ltd, Key Competitors 12

Renata Ltd, Key Employees 13

Renata Ltd, Other Locations 14

Renata Ltd, Subsidiaries 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Renata Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.